Johnson Investment Counsel’s Core Laboratories CLB Stock Holding History

Johnson Investment Counsel’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,673	Closed	-$207K	–	572
2016 Q2	$207K	Buy	+1,673	New	+$202K	0.01%	517
2015 Q1	–	Sell	-2,030	Closed	-$244K	–	545
2014 Q4	$244K	Sell	2,030 -250	-11%	-$32.8K	0.01%	490
2014 Q3	$333K	Sell	2,280 -75	-3%	-$11.6K	0.01%	412
2014 Q2	$393K	Sell	2,355 -345	-13%	-$61.4K	0.01%	347
2014 Q1	$535K	Sell	2,700 -260	-9%	-$49.1K	0.02%	263
2013 Q4	$565K	Sell	2,960 -79	-3%	-$14.7K	0.02%	260
2013 Q3	$514K	Sell	3,039 -414	-12%	-$64.3K	0.02%	252
2013 Q2	$523K	Buy	+3,453	New	+$489K	0.02%	239

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Johnson Investment Counsel's CLB Position: Q3 2016 in Review

Johnson Investment Counsel sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 1,673 shares — an estimated $207K sold.

Johnson Investment Counsel first reported a position in CLB in Q2 2013 and held it in 8 quarters. The position peaked at $565K in Q4 2013. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

Johnson Investment Counsel reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
Johnson Investment Counsel sold 1,673 Core Laboratories shares in Q3 2016, an estimated $207K.
Johnson Investment Counsel first reported a position in Core Laboratories in Q2 2013 and held it in 8 quarters.
Johnson Investment Counsel's Core Laboratories position peaked at $565K in Q4 2013.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Johnson Investment Counsel's 13F filing for Q3 2016, filed 14 Nov 2016.